Usually the decision is based on assessment of risks and benefits if the possibility of thromboembolic events and risk of bleeding must be considered.
Usualmente, la decisión se basa en un balance riesgo beneficio entre la probabilidad de eventos tromboembólicos y el riesgo de resangrado.